Corallina officinalis: A Comprehensive Encyclopedic Reference
1. Identity, Taxonomy, and Natural Source
1.1 Scientific Classification
Corallina officinalis Linnaeus, 1758, commonly known as coral weed, is a geniculate (articulated) red alga in the family Corallinaceae, characterized by its calcareous, segmented, and branching fronds that typically grow erect to heights of up to 12 cm, though often shorter, arising from a crustose holdfast. The species was formally published by Linnaeus in 1758 in Systema Naturae, Tomus I, Editio Decima.
Taxonomically, C. officinalis is classified within the domain Eukaryota, kingdom Plantae, subkingdom Biliphyta, infrakingdom Rhodaria, phylum Rhodophyta, subphylum Eurhodophytina, class Florideophyceae, subclass Corallinophycidae, order Corallinales, family Corallinaceae, subfamily Corallinoideae, tribe Corallineae, genus Corallina, and species C. officinalis Linnaeus 1758. Corallina officinalis is the type species (lectotype) of the genus Corallina.
The species epithet officinalis derives from Latin, meaning "used in medicine [in the past]." The genus name Corallina derives from the Latin word corallium, meaning "coral," which reflects the plant-like appearance and calcified form of the alga, resembling coral.
1.2 Common Names
- Coral weed (English, most common)
- Coral moss (recorded in some Scandinavian usage)
- Common coralline (used in naturalist contexts)
1.3 Morphology
Corallina officinalis consists of calcareous, branching, segmented fronds, usually erect, up to 12 cm high but often much shorter. Fronds rise from a calcareous crustose, disk-shaped holdfast about 70 mm in diameter, and consist of a jointed chain of calcareous segments, each becoming wedge-shaped. It forms calcium carbonate deposits within its cells, which serve to strengthen the thallus. These white deposits cause the seaweed to appear pink in colour, with white patches where the calcium carbonate is particularly concentrated, such as at the growing tips. The calcium carbonate makes it unpalatable to most rocky shore grazers.
The fronds form jointed chains of wedge-shaped segments with opposite branching, giving a pinnate, feather-like appearance, and exhibit colors ranging from purple and red to pink or yellowish, often paling under high light due to pigment degradation.
1.4 Distribution and Habitat
Corallina officinalis is a calcareous red seaweed which grows in the lower and mid-littoral zones on rocky shores. It is primarily found growing around the rims of tide pools, but can be found in shallow crevices anywhere on the rocky shore that are regularly refreshed with sea water. C. officinalis is common, found on solid rock around Great Britain, Ireland and the Isle of Man. It is also recorded from the North Atlantic coast, from northern Norway to Morocco, and intermittently from Greenland to Argentina, as well as in USA, Argentina, Japan, China, Australia, and New Zealand.
1.5 Common Forms and Preparations
Several distinct material forms of Corallina officinalis appear in commerce and research:
- Dried whole thallus / dried powder: The fronds are dried and converted to hydroxyapatite for use as a bone-forming material. It is also sold as a powder for use in the cosmetic industry.
- Aqueous/solvent extract (Corallina Officinalis Extract): An extract of the whole alga, Corallina officinalis, produced by various extraction processes. Corallina Officinalis Extract is reported to be used in 96 cosmetic formulations.
- Hydrolyzed Corallina Officinalis Extract: A product of the aqueous extraction of the whole alga, subject to hydrolysis during processing.
- Coralline hydroxyapatite (CHA): A medical-grade material manufactured from marine coral or coralline algae by the hydrothermal conversion of the calcium carbonate skeleton to hydroxyapatite, a calcium phosphate.
2. Traditional and Historical Use
2.1 European Tradition: Vermifuge
Corallina officinalis has been utilized in traditional European medicine primarily as a vermifuge to expel intestinal worms, a practice documented since ancient times in Mediterranean countries. This species was used in Europe as a vermifuge, although it no longer seems to be collected for this purpose. The species name "officinalis" refers to use of this seaweed in medicine, as with other species containing that name. It was used in early Europe to expel intestinal worms, and it is still used in medicine today when dried and converted to a substance used in bone grafting.
2.2 Traditional Mineral and Bone Health Uses
Historically, this marine plant held an esteemed place in traditional medicine, especially in coastal regions of Europe. Folk healers valued Corallina officinalis as a natural remedy for strengthening bones and teeth, leveraging its abundant calcium to address rickets, osteoporosis, and other conditions linked to mineral deficiencies. The powdered alga was often consumed as a tonic to support general vitality and replenish essential minerals after illness or during convalescence.
2.3 Agricultural and Coastal Dietary Use
Historically, it has been utilized as a natural source of minerals in coastal diets and as a soil amendment in agriculture.
2.4 External / Wound Uses
Historical records and ethnobotanical surveys suggest that powdered or macerated forms of this alga were sometimes applied externally with the intention of promoting wound healing or reducing inflammation. However, the evidence supporting this use is largely anecdotal and not systematized.
3. Key Constituents and Active Compounds
3.1 Mineral Matrix: Calcium Carbonate
C. officinalis forms calcium carbonate deposits within its cells, which serve to strengthen the thallus. This highly calcified structure is the dominant inorganic constituent, and its conversion to hydroxyapatite underlies the alga's primary modern medical application. The chemical composition of Corallina officinalis is rich and varied, containing several bioactive compounds, and it is particularly high in calcium carbonate, which forms its hard, calcified structure.
3.2 Phycobiliprotein Pigments
Corallina officinalis is characterized by the presence of phycoerythrin pigments and a lack of flagella in reproductive cells. Phycoerythrins are red fluorescent pigments that belong to the phycobiliprotein family and are responsible for the alga's distinctive color. Carotenoids including lutein have also been identified among the photosynthetic pigments.
3.3 Phenolic Compounds and Flavonoids
Qualitative investigation has verified the existence of essential bioactive components including phenols, flavonoids, sterols, polysaccharides, and terpenoids. Seaweed is well recognized as a significant source of bioactive compounds, including proteins, polysaccharides, lipids, and polyphenols, due to the fact that these chemicals exhibit significant antibacterial, anticancer, antioxidant, antifungal, and antiviral effects. Methanolic extraction yields the highest concentrations of phenolics and flavonoids, followed by chloroform and hexane fractions.
3.4 Sulfated Polysaccharides
The alga's antioxidant defense system is powered with sulfated polysaccharide chains, rich in galactose and xylose monomers that protect algal cells from free radicals and peroxides. The presence of sulfated polysaccharides in macroalgae cellular walls, particularly in the fibril matrix and intercellular gaps, gives the alga a great capacity to bind contaminants. The polysaccharide hydroxyl, sulfate, and carboxyl groups are powerful ion exchangers. Some polysaccharides break apart (hydrolyze) during extraction into galactose and xylose, which are small-molecule sugars that improve the skin's moisture-binding ability and may nourish beneficial bacteria, producing a prebiotic effect.
3.5 Mycosporine-Like Amino Acids (MAAs)
Corallina officinalis produces MAAs (mycosporine-like amino acids) that absorb the UV spectrum of light, protecting the plant from radiation. MAAs are typically small (<400 Da), colourless, water-soluble compounds, of which over 20 are currently known. They have a similar general structure based on 4-deoxygadusol, containing cyclohexenone or cyclohexenimine rings conjugated to the nitrogen substituent of an amino acid or imino alcohol. These can undergo further carboxylation or demethylation, which changes their UV radiation absorption properties. MAAs are involved in photoprotection from damaging UVR thanks to their ability to absorb light in both the UV-A (315–400 nm) and UV-B (280–315 nm) range without producing free radicals. In addition, by scavenging reactive oxygen species (ROS), MAAs play an antioxidant role and suppress singlet oxygen-induced damage.
3.6 Terpenoids and Sterols
The triterpene squalene has been identified in supercritical CO2 extracts of C. officinalis, present at 13.64%. Seasonal investigations have examined the lipid compound content of C. officinalis, and sterols of the Corallinaceae family have been characterized in related species.
3.7 Additional Metabolites
Some primary and secondary metabolites identified in C. officinalis include phytochromes (lutein and carotenoids), DHA, tannins, peptides, lipids, enzymes, vitamins, and terpenoids. Amino acids and seasonal lipid compositions have also been the subject of earlier biochemical investigations.
4. Mechanisms of Action
4.1 Antioxidant Mechanisms
Methanolic extracts of C. officinalis demonstrate superior antioxidant performance, with a DPPH radical scavenging rate of 78.71% and a reducing power corresponding to an absorbance of 1.16 at 700 nm. The sulfated polysaccharides and phenolic compounds are believed to be primary contributors to this activity through radical neutralization and metal chelation.
4.2 UV Photoprotection (MAA Mechanism)
The ability of MAAs to absorb UV radiation and dissipate energy as heat without generating reactive photoproducts makes them significant photoprotective compounds. Certain photosynthetic organisms such as algae and cyanobacteria have evolved to cope with exposure to UVR by producing mycosporine-like amino acids (MAAs). In the case of C. officinalis, these compounds contribute a dual UV-absorbing and antioxidant defense capacity relevant to both the alga's survival and its application in topical photoprotection.
4.3 Osteoconductive Mechanism (Hydroxyapatite)
The efficacy of coralline hydroxyapatite derived from marine algae has been well established through multiple human and animal studies. Coralline hydroxyapatite enhances osteogenesis by providing a biocompatible lattice for the passage and assembly of vascular, fibroblastic, and osteoblastic tissues, while also providing support for surrounding osseous structures.
4.4 Antimicrobial Mechanisms
Phenolic compounds, a crucial class of secondary metabolites, are involved in vital biological processes such as antibacterial, anticarcinogenic, anti-inflammatory, and therapeutic activities. The presence of sulfated polysaccharides with negatively charged surface functional groups has also been associated with antimicrobial effects by disrupting cell membrane integrity.
5. Scientific Evidence by Area of Use
5.1 Bone Grafting and Orthopedic Applications
The conversion of coralline calcium carbonate to hydroxyapatite for surgical bone grafting is the most clinically developed application associated with coralline algae.
The fronds of Corallina officinalis are dried and converted to hydroxyapatite and used as a bone-forming material. Coralline hydroxyapatite (CHA) is manufactured by the hydrothermal conversion of the calcium carbonate skeleton of coral or coralline alga to hydroxyapatite, a calcium phosphate. While many studies have demonstrated promising biocompatible properties and osteogenic results as a bone graft substitute and bone void filler, the use of CHA may be limited owing to its inherent mechanical weakness and reduced biodegradation. The benefits of CHA as a bone graft are predominantly its safety, biocompatibility, and osteoconductivity.
Animal studies: Experimental histologic and biomechanical studies were performed in 52 dogs using a bone substitute composed of hydroxyapatite converted from sea coral calcite, demonstrating potentially useful practical applications. The material was totally incorporated in bone. Although initially too weak to tolerate physiologic stresses, once incorporated it becomes almost as strong as native bone. Clinical experience with internal fixation of fractures with hydroxyapatite in 18 patients was reported as encouraging.
Human/clinical data: Hydroxyapatite developed from sea coral has been utilized as a bone implant. The primary application is in maxillofacial surgery along with experimental use in orthopedic surgery. The acceptance of this implant in bone and by the body has been found to be excellent without signs of rejection or increase in the incidence of infection.
One series examined the clinical and arthrodesis efficacy of coralline hydroxyapatite as an osteoconductive bone graft substitute in the anterior lumbar spine using a titanium mesh cage in 50 patients returning for long-term prospective follow-up. Pain was measured with a visual analog scale and function with the Oswestry Disability Index.
Evidence strength: Moderate-to-good for the surgical bone-graft/hydroxyapatite application, supported by multiple animal and human case series. Limitations include the fact that most human data derive from case series rather than randomized controlled trials, and the mechanical weakness of the material in load-bearing sites remains a noted limitation.
5.2 Antioxidant Activity
In recent years, there has been increasing scientific interest in the antioxidant phytochemicals found in macroalgae extracts, given their crucial role in disease prevention. The methanolic extract of Corallina officinalis from the Algerian coast demonstrated a DPPH radical scavenging rate of 78.71% and a reducing power corresponding to an absorbance of 1.16 at 700 nm. Differences in bioactive compound content among studies may result from variations in algal material and extraction methods.
Evidence strength: Preliminary; all current antioxidant evidence is from in vitro laboratory studies. No human clinical trials assessing antioxidant outcomes specifically from C. officinalis supplements are available in the published record.
5.3 Antimicrobial Activity
The anti-inflammatory, anti-arthritic, and antimicrobial activities of C. officinalis among common Egyptian seaweeds have been investigated. Phytochemical screening of seaweed extracts showed the presence of different primary and secondary metabolites with different concentrations according to species and the solvent used. The dichloromethane extract of Corallina officinalis exerted the highest antimicrobial activity among the tested species, with an average inhibition zone diameter of 15.29 mm and an activity index of 1.53, and with the highest antagonistic activity against Escherichia coli (28 mm).
One research group focused on developing antimicrobial and antioxidant nanofibrous wound dressings using chitosan, polyvinyl alcohol (PVA), and crude Corallina officinalis extract (COE) via electrospinning, with a comprehensive evaluation of morphology, structure, mechanical properties, wettability, biodegradation rate, and biological activities. Antibacterial tests showed a zone of inhibition measuring 28.00 ± 0.10 mm against Escherichia coli and 22.00 ± 0.20 mm against Staphylococcus aureus when using a 3% concentration of COE. The fabricated dressings effectively prevented bacterial penetration, resulting in negligible colony growth in the culture media.
Evidence strength: Preliminary; all current antimicrobial evidence is from in vitro and laboratory studies. No human clinical trials exist.
5.4 Anti-Inflammatory Activity
Nanofiber dressings incorporating C. officinalis extract significantly enhanced biological activities, particularly antioxidant and anti-inflammatory effects. In the study examining Egyptian seaweeds, the dichloromethane and other extracts of C. officinalis were tested for protein denaturation inhibition as a proxy for anti-arthritic activity, though C. officinalis did not rank as the most potent species for anti-inflammatory endpoints in that comparison.
Evidence strength: Preliminary; in vitro and laboratory model data only. No controlled human trials.
5.5 Potential Anticancer / Cytotoxic Activity
Polysaccharide crude extracts of Corallina officinalis (Rhodophyta) have been reported to significantly inhibit human breast MCF-7, colon cancer CoCa2, and liver cancer cell line HePG2 cell proliferation in vitro when compared to the reference drug doxorubicin.
Researchers have also investigated gold nanoparticles biosynthesized using C. officinalis extracts. Gold nanoparticles (GNPs) biosynthesized with an aqueous extract of the red alga Corallina officinalis, used as a reducing and stabilizing agent, exhibited potent cytotoxic activity against MCF-7 (breast cancer) cells. El-Kassas and El-Sheekh (2014) reported a cytotoxic effect of gold nanoparticles with aqueous extract of Corallina officinalis collected from Egypt against human breast cancer cells.
Research into the anti-breast cancer stem cell activity of Corallina officinalis polysaccharides has also been published, with molecular mechanism investigations noted in the literature.
Evidence strength: Very preliminary; all data are from in vitro cell-culture studies. No animal in vivo studies or human clinical trials have evaluated C. officinalis as a cancer treatment. In vitro cytotoxicity does not predict clinical efficacy.
5.6 UV Photoprotection and Skin Applications
Biocompatible MAAs, which occur naturally in a wide range of marine species including coralline algae, have a role in nature that is mainly thought to be photoprotective. However, their potential for human photoprotection is largely understudied. MAAs have well-documented applications in cosmetics, toiletries, as UV protectors, and as activators of cell proliferation and suppressors of UV-induced aging in human skin.
Although it is well recognized that MAAs are ultraviolet (UV) protective agents that can reduce UV damage, the specific biological mechanism of their role in the skin remains unclear. Studies on MAAs from other marine organisms (not specifically C. officinalis) have shown that MAAs alleviated skin swelling and epidermal thickening in mice exposed to UVB; reactive oxygen species (ROS), malondialdehyde, and collagen content in skin tissue were assessed, and MAA components protected against UVB-induced skin damage by inhibiting ROS generation, relieving skin inflammation, and slowing collagen degradation.
Evidence strength: The MAA photoprotection mechanism is well established at the in vitro and preclinical level. Specific clinical human trials using C. officinalis-derived MAAs as a topical photoprotective agent have not been identified in the published literature. The cosmetic use is documented by industry and regulatory sources.
5.7 Wound Healing
Nanofiber dressings significantly enhance the biological activities of Corallina officinalis extract (COE), particularly its antioxidant and anti-inflammatory effects, suggesting applicability to wound care. The combination of antioxidant and antimicrobial properties in C. officinalis extracts has motivated research into wound dressing biomaterials, though this work remains at the laboratory and material-science stage.
Evidence strength: Preclinical laboratory/material science only. No human wound-healing trials have been conducted.
6. Body Systems and Health Areas of Association
- Skeletal / Musculoskeletal System: Historically used for bone and tooth mineral support; modern medical use as a source for coralline hydroxyapatite bone-graft material.
- Integumentary System (Skin): Cosmetic and topical applications leveraging antioxidant, UV-protective (MAA-based), remineralizing, and anti-inflammatory activities.
- Gastrointestinal System: Traditional anthelmintic (vermifuge) use; historical internal use as a mineral tonic.
- Immune / Anti-infective System: In vitro antibacterial activity identified against E. coli and S. aureus; in vitro antifungal potential.
- Oncology (Research-Stage): In vitro cytotoxic activity against breast, colon, and liver cancer cell lines.
7. Dosage Forms and Reported Dosages
No standardized oral dietary supplement dosage for Corallina officinalis has been established in peer-reviewed clinical trials or by any regulatory monograph. The following dosages appear specifically in the cited sources:
- Cosmetic topical use (extract): A concentration-of-use survey indicates that Corallina Officinalis Extract has a highest reported maximum concentration of use of up to 2% in blushers, other makeup preparations, and face and neck products.
- Sensitization/safety studies (topical): Testing in human sensitization studies used Corallina Officinalis Extract at 0.2–4% (algae content) and Hydrolyzed Corallina Officinalis Extract at 0.5–3%.
- Acute oral toxicity (animal, extract mixture): The acute oral toxicity of a mixture containing water and Corallina Officinalis Extract (0.2–4% algae) was evaluated in 10 rats. The LD50 was reported to be >5000 mg/kg. No other details regarding this study were provided.
- Laboratory antibacterial testing: A 3% concentration of COE produced a zone of inhibition of 28.00 ± 0.10 mm against E. coli and 22.00 ± 0.20 mm against S. aureus.
- In vitro cytotoxicity (mammalian cells): Among tested extracts, only Corallina officinalis extract showed some weak cytotoxic potential towards mammalian (rat skeletal myoblast L6) cells at a half maximal inhibitory concentration (IC50) value of 88.6 µg/mL.
8. Safety Considerations
8.1 Regulatory Safety Status (Cosmetic Use)
The Cosmetic Ingredient Review (CIR) Expert Panel issued a Final Report concluding that 16 of the 60 distinct red algae-derived ingredients reviewed are safe in the present practices of use and concentration described in the safety assessment. Recent reported use of Corallina officinalis as an emulsifier in food products was sufficient to alleviate systemic toxicity concerns regarding the Corallina officinalis-derived ingredients.
8.2 Weak In Vitro Cytotoxicity Signal
Among the red algae extracts tested for cytotoxic potential using rat skeletal myoblasts (L6-cells), only Corallina officinalis showed some weak cytotoxic potential towards the mammalian cells, with an IC50 value of 88.6 µg/mL. The remaining extracts had no toxicity at the highest concentration tested. This in vitro finding was considered in the CIR assessment; the regulatory conclusion of safety for cosmetic use was maintained at reported use concentrations.
8.3 Heavy Metal Accumulation Potential
Research on macroalgae from the Alexandria coast found that Corallina officinalis and Corallina elongata demonstrated a high capacity for cadmium (Cd), lead (Pb), and nickel (Ni) accumulation. A mineral and heavy metal analysis of a commercial trade name mixture containing 1.5% Corallina Officinalis Extract detected iodine, arsenic, cadmium, mercury, and lead at levels of 1.9 mg/l, 1383 µg/kg, 29 µg/kg, <10 µg/kg, and 86 µg/kg, respectively. This known capacity for heavy metal bioaccumulation means that the geographic origin, harvest conditions, and purification processes are significant quality variables for any C. officinalis-derived product intended for human use.
8.4 Iodine Content
As with other marine algae, C. officinalis may contain iodine. The CIR analysis of a commercial mixture detected iodine at 1.9 mg/l, a factor of relevance for persons with thyroid conditions or iodine-sensitive individuals consuming algae-derived products internally.
8.5 Absence of Clinical Interaction Data
No published peer-reviewed clinical studies have specifically documented pharmacokinetic drug-herb interactions for Corallina officinalis preparations. The limited available data concern the cosmetic topical route of exposure rather than oral supplementation.
8.6 Evidence Gaps
More research is needed to assess the nutritional characteristics and mechanisms underlying the health benefits of various macroalgal products. The totality of published evidence for C. officinalis as a dietary or oral supplement consists exclusively of in vitro and preliminary laboratory data. No randomized controlled trials, systematic reviews, or established clinical guidelines address oral supplementation with this species in humans.
References
Go back